Viscomi, Giuseppe Claudio,Maffei, Paola,Bottoni, Giuseppe,Grimaldi, Maria
申请号:
HRP20171734
公开号:
HRP20171734T1
申请日:
2017.11.13
申请国别(地区):
HR
年份:
2018
代理人:
摘要:
Disclosed herein are methods of treating a patient having an intestinal disorder, the methods comprising: administering to a patient in need thereof a pharmaceutical composition comprising a hydrate or solvate form of rifaximin in polymorphic form &bgr;, alone or in a mixture with other crystalline, hydrate, solvate or amorphous forms of rifaximin, in gastroresistant microgranules, wherein the rifaximin is administered at a dose of at least 800 mg per day for a period of at least 7 days.